Answers are grounded in this paper and cite their sources.
Literature review highlights the negative effects of benzodiazepines on cognition and quality of life in schizophrenia patients, suggesting scrutiny on guidelines.
Introduction Emerging data suggest that benzodiazepines are not appropriate for patients in the long-term management of schizophrenia. Methods A literature search was conducted on studies published on the topic of benzodiazepines and schizophrenia from 2004 to 2024. The search returned more than 3000 results of which 27 were relevant to include in this scoping review. Results The publications identified for this review spanned benzodiazepines’ negative impact on mortality, hospitalizations, brain volume changes, cognition, global functioning, and quality of life. There were also publications identified to evaluate the current evidence for use in schizophrenia as well as related conditions, such as tardive dyskinesia, akathisia, and catatonia. Discussion Based on the currently available guidelines, there seems to be a lack of a clear stance against the regular use of benzodiazepines in schizophrenia. These organizations should be more straightforward about the specific potential uses and risks associated with benzodiazepine use in schizophrenia.
No takes yet. Share an insight, caveat, or question.
Christopher Noel (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: